Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127103891 | 12710389 | 1 | I | 20061003 | 20160902 | 20160902 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-13530860 | BRISTOL MYERS SQUIBB | 7.00 | MON | M | Y | 3.90000 | KG | 20160902 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127103891 | 12710389 | 1 | PS | VIDEX | DIDANOSINE | 1 | Oral | 7 MG, QD | U | 20156 | 7 | MG | QD | ||||||
| 127103891 | 12710389 | 2 | SS | RETROVIR | ZIDOVUDINE | 1 | Oral | 8 MG/KG, UNK | U | 0 | 8 | MG/KG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127103891 | 12710389 | 1 | HIV infection |
| 127103891 | 12710389 | 2 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127103891 | 12710389 | OT |
| 127103891 | 12710389 | HO |
| 127103891 | 12710389 | CA |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127103891 | 12710389 | Blood lactic acid increased | |
| 127103891 | 12710389 | Foetal exposure during pregnancy | |
| 127103891 | 12710389 | Macrocephaly | |
| 127103891 | 12710389 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |